Securities Contracts (Regulation) Amendment Rules, 2026
The Securities Contracts (Regulation) Rules, 1957 prescribe minimum public shareholding and listing requirements for companies. These provisions apply to companies issuing equity shares or convertible securities for public listing.
Establishment and Revision of Indian Standards (March 2026)
The Bureau of Indian Standards issues notifications for establishment, revision, and withdrawal of Indian Standards applicable to various products and processes. These standards apply to manufacturers, laboratories, and stakeholders relying on BIS specifications.
Regulatory Reforms for Food Safety Licensing and Registration Framework
The existing framework required periodic renewal of FSSAI registrations and licences for food business operators and prescribed turnover-based thresholds for registration and licensing.
SEBI Corrigendum to Notification dated March 3, 2025
The Securities and Exchange Board of India had earlier issued a notification dated March 3, 2025, published in the Gazette of India, Extraordinary, Part III, Section 4, introducing amendments relating to Schedule X.
Advisory on confirmation of “Tax Liability Breakup, As Applicable” in GSTR-3B
From February 2026 onwards, the GST Portal has enabled auto-population of such breakup based on supplies reported in GSTR-1/GSTR-1A/IFF. The advisory clarifies the process for confirmation of such liability breakup.
Establishment of Multiple Indian Standards by Bureau of Indian Standards
The Bureau of Indian Standards issues notifications under Rule 15(1) of the Bureau of Indian Standards Rules, 2018 to establish new or revised Indian Standards and to specify withdrawal dates for superseded standards.
Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Amendment Order, 2026
The Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013 regulates specified controlled substances used in the manufacture of narcotic drugs and psychotropic substances.
Draft Amendment to Drugs Rules, 1945 on Reporting of Manufacturing Changes
The Central Government has issued draft rules proposing amendments to the Drugs Rules, 1945 after consultation with the Drugs Technical Advisory Board.
Delhi Shops and Establishments (Amendment) Act, 2026
The Delhi Legislative Assembly passed the Delhi Shops and Establishments (Amendment) Act, 2026 on January 09, 2026, which received the assent of the President of India on February 23, 2026.
Corrigendum to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Amendment
The Securities and Exchange Board of India had issued Notification No. SEBI/NRO-GN/2026/295 dated January 20, 2026 amending the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which was published in the Gazette of India, Extraordinary, Part III, Section 4.